Selection of Antihypertensive Drug

Slides:



Advertisements
Similar presentations
CE REVIEW UNDERSTANDING HYPERTENSION. Hypertension is a chronic medical condition affecting more than 65 million Americans. Controlling hypertension is.
Advertisements

The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
Assessment and Management of Patients With Hypertension.
Hypertension – Summary
B) Drug Therapy (Antihypertensives) ACEi B.B CCB D iuretics. Centrally acting agents: alphametyldopa, HTN + pregnancy.
Antihypertensives or How not to blow your cork. Background  Cardiovascular pharmacology must always deal with two problems 1. Treating the disease state.
Cardiology Review: HTN Julia Akaah M.D.. Of the estimated 50 million Americans that have HTN (average BP>140/90): Of the estimated 50 million Americans.
ANTIHYPERTENSIVE Rx MED PHARM CARDIOVASCULAR DISEASE (CVD) Leading cause of death in the US 36% of deaths, 900,000 per year 52% due to coronary.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Antihypertensives Chad Byworth. Hypertension What is hypertension? Blood pressure of greater than 140 systolic or 90 diastolic, confirmed in primary care.
2003 Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)
Pharmacological Treatment of Hypertension Update 2012.
Hypertension and The Older Patient
Hypertension in the Elderly
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
HYPERTENSION NMP. How Common? 25% UK adults 25% UK adults > 50% adults over 60 > 50% adults over 60.
Drugs for Hypertension
1 The JNC 7 recommendations for initial or combination drug therapy are based on sound scientific evidence.
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
1 ANTIHYPERTENSIVE DRUGS. 2 3 Definition Elevation of arterial blood pressure above 140/90 mm Hg. Can be caused by: - idiopathic process (primary or.
1 1 Individualized Therapy forHypertension Introduction to Primary Care: a course of the Center of Post Graduate Studies in FM PO Box – Riyadh
ACUTE STROKE — Hypertension is a common problem in patients with both type 1 and type 2 diabetes but the time course in relation to the duration.
 Edmond 75 years presented with ‘shocking” blood pressure recordings of 184/102 in the morning. His afternoon and night readings were in the ‘acceptable.
Selection of Antihypertensive Drug. BP ClassificationSystolic BP, mm Hg Diastolic BP, mm Hg Normal
 Hypertension : BPDIASTOLIC SYSTOLIC Normal< 130< 85 Mild hypertension Moderate hypertension Severe Hypertension 180.
PHOTO OF Dr. Thomas 1 Summary of Guidelines JNC VI guidelines focus on: - Absolute risks and benefits used in compiling recommendations - Strong emphasis.
0CTOBER 2010 An Approach for Sub-Saharan Africa. Dr. Linda Hawker, MD, CCFP General Practice Kelowna BC Canada.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Investigations: Urine examination. Urine examination. Serum K. Serum K. Serum creatinine. Serum creatinine. Blood Sugar. Blood Sugar. Hb. Hb.
Hypertension  Classification of hypertension  BP targets  Basic evaluation  When to evaluate for secondary causes  Which drug(s) you should use 
1 Current & New treatment strategies to address CV Risk.
UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,
Clinical Aspects of Hypertension Anna Maio, M.D..
Antihypertensives Dr Thabo Makgabo.
Hypertension Dr Nidhi Bhargava 8/10/13. Why Treat Increased risk of cardiovascular death and mortality Increased systolic, diastolic and pulse pressures.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
HYPERTENSION RECOMMENDATIONS FOR FOLLOW UP BASED ON INITIAL BP READING
PHARMACOTHERAPY OF HYPERTENSION Based on New Guidelines Fariborz Nikaeen; MD Interventional cardiologist 2 november 2015.
Hypertension Treatment Dr.Negin Nezarat. 1.mechanisms and cardiovascular pathophysiology (Review). 2.major forms of clinical hypertension. 3.major classes.
Diuretics and Antihypertensives
Clinical Pharmacology of Drugs for Controlling Vascular Tone
ANTIHYPERTENSIVE DRUGS
بسم الله الرحمن الرحيم.
Hypertension Hypertension can be classified as follows: Mild :Diastolic pressure mmHg Moderate: Diastolic pressure mmHg Sever: Diastolic pressure.
Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle.
Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).
MACROVASCULAR COMPLICATIONS, DYSLIPIDEMIA and HYPERTENSION 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Effect of some adrenergic drugs and its blockers on the blood pressure.
 Prazosin, doxazosin, and terazosin  They causing relaxation of both arterial and venous smooth muscle. Postural hypotension may occur in some individuals.
Drugs for Hypertension
JNC VIII Hypertension.
Hypertension JNC VIII Guidelines.
Drugs for Hypertension
ANTI-HYERTENSIVE DRUGS: Therapeutic overview
Achieving the Clinical Potential of RAAS Blockade
UNIT 2: ANTIHYPERTENSIVE DRUGS
UNIT 2: ANTIHYPERTENSIVE DRUGS
Antihypertensive Drugs
Essential Hypertension
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Diagnosis and management of Hypertension
Primary Hypertension Max C. Reif, M.D.
Anti hypertensive Drugs
Chapter 32 Assessment and Management of Patients With Hypertension
Hypertension is defined as systolic blood pressure (SBP) of 140 mmHg or greater, diastolic blood pressure (DBP) of 90 mmHg or greater, or taking antihypertensive.
The following slides highlight a report by Dr
Presentation transcript:

Selection of Antihypertensive Drug

Selection of Antihypertensive Drug Alpha Blocker AT1Antagonist  - agonists ACE Inhibitor Ganglionic blockers Dr. Rx Rational Drug of choice Beta Blocker Vasodilators Ca++ Antagonist Diuretic

Selection of Antihypertensive Drug Level of blood pressure + Presence of other risk factors for CVD & target organ damage Coexisting diseases 1 2 3 Antihypertensive Therapy

Pharmacotherapy of Hypertension

Pharmacotherapy of Hypertension Target organ damage/clinical CVD LVH - Heart failure - Angina - Prior MI or revascularization Stroke or TIA Nephropathy Retinopathy Peripheral vascular disease

Blood Pressure Classification JNC 7 SBP DBP mm Hg mmHg Normal Prehypertensive Stage 1 Hypertension Stage 2 Hypertension <120 and <80 120-139 or 80-89 140-159 or 90-99 > 160 or > 100

Goal Blood Pressure JNC 7 < 140 < 90 < 130 < 80 mm Hg mmHg SBP DBP mm Hg mmHg Most patients Diabetes Chronic Renal Disease < 140 < 90 < 130 < 80

Lifestyle Modifications JNC 7 Lifestyle Modifications Approximate SBP Reduction mmHg 5 – 20 8 – 14 2 – 8 4 – 9 2 – 4 Weight reduction DASH eating plan Reduced Sodium Intake Physical activity Moderation of alcohol consumption

Algorithm for Treatment of Hypertension JNC 7 Algorithm for Treatment of Hypertension Lifestyle Modifications Not at Goal Blood Pressure Initial Drug Choices

Algorithm for Treatment of Hypertension JNC 7 Algorithm for Treatment of Hypertension Initial Drug Choices “Excellent clinical trial outcome data prove that lowering BP with several classes of drug, including ACE inhibitors, angiotensin receptors blockers (ARBs),”beta-blockers”, calcium channel blockers (CCBs) and thiazide-type diuretics will reduce the complications of hypertension.”

Algorithm for Treatment of Hypertension JNC 7 Initial Drug Choices Without Compelling Indication (s) With Compelling Indication (s)

Algorithm for Treatment of Hypertension JNC 7 Initial Drug Choices Stage 1- Hypertension 140-159 / 90-99 mmHg Without Compelling Indication Thiazide-like diuretics for most, ACEI, ARB, BB or CCB May consider combination

Algorithm for Treatment of Hypertension JNC 7 Initial Drug Choices Stage 2 - Hypertension >160 / > 100 mmHg Without Compelling Indication 2-drug combination for most Usually thiazide-like diuretic plus ACEI, or ARB, or BB or CCB

Algorithm for Treatment of Hypertension JNC 7 Initial Drug Choices Without Compelling Indication (s) With Compelling Indication (s) Not at Goal Blood Pressure Optimize dosage or add additional drug until goal BP is achieved. Consider consultation with HNT specialist

Clinical trial and guideline basis for compelling indications for individual drug classes Diuretic BB ACEI ARB CCB ALD & ANT Heart failure ● Postmyocardial infarction High coronary disease risk Diabetes Chronic kidney disease Recurrent stroke prevention

Class Drug (Trade Name) Usual Dose Range in mg/Day Usual Daily Frequency* Thiazide diuretics chlorothiazide chlorthalidone hydrochlorothiazide polythiazide indapamide metolazone 125–500 12.5–25 12.5–50 2–4 1.25–2.5 0.5–1.0 2.5–5 1–2 1 Loop diuretics bumetanide furosemide torsemide 0.5–2 20–80 2.5–10 2 Potassium-sparing diuretics amiloride triamterene 5–10 50–100 Aldosterone receptor blockers eplerenone Spironolactone 25–50

Class Drug (Trade Name) Usual Dose Range in mg/Day Usual Daily Frequency* BBs Atenolol Propranolol propranolol long-acting 25–100 40-160 60-180 1 2 Combined alpha- and Carvedilol labetalol 12.5–50 200–800 ACEIs enalapril ramipril 5-40 2.5-20 1-2 Angiotensin II antagonists losartan 25-100 CCBs—nondihydropyridines diltiazem extended release verapamil immediate release verapamil long acting Verapamil 180-420 120-540 80-320 120-480 120-360

Class Drug (Trade Name) Usual Dose Range in mg/Day Usual Daily Frequency* CCBs-dihydropyridines amlodipine nifedipine long-acting 2.5-10 30-60 1 Alpha-1 blockers doxazosin prazosin terazosin 1-16 2-20 1-20 2-3 1-2 Central alpha-2 agonists and other centrally acting drugs clonidine clonidine patch methyldopa reserpine guanfacine 0.1-0.8 0.1-0.3 250-1000 0.1-0.25 0.5-2 2 1 wkly Direct vasodilators hydralazine minoxidil 25-100 2.5-80

Hypertension in Elderly Pharmacological treatment: - Lower initial doses (1/2 dose than in younger patients) - The reduction in BP should be gradual - Greater caution in patients with co-existing diseases or orthostatic hypotension. Choice of therapy: - Thiazide diuretic (hydrochlorothiazide, HCTZ 12.5 mg) - STOP-Hypertension trial: ACE inhibitors, long-acting calcium antagonist and beta- blockers may provide the same protection as diuretics.

Hypertension in Elderly Choice of therapy: special considerations A diuretic should be used for heart failure or edema A beta-blocker should be used for patient with coronary heart disease, tachyarrhitmias or migraine An ACE inhibitors in patients with heart failure Calcium antagonist should be used in patients with angina pectoris,and peripheral vascular disease Alpha-blocker in patient with benign prostatic hyperplasia

Hypertension and Diabetes Treatment: Early treatment to prevent cardiovascular disease and minimize progression of renal and retinal disease. The benefits of tight blood pressure control in diabetics may be as great or greater than benefits of strict glycemic control. Initial therapy should include non-pharmacological methods. ACE Inhibitors, ARBs, C++ Channel Blockers,

Hypertension and Diabetes Kidneys in diabetic patients are more sensitive to any increase in blood pressure Proteinuria is not only the marker of renal damage, but also risk factor for progression of renal disease Pathogenesis:

Asthma COPD and Hypertension Beta-blockers (i) increase bronchial obstruction, (ii) increase in airways reactivity, and (iii) inhibit the bronchodilatatory effects of beta agonist Cardioselective, beta-blockers none should be considered safe.Even topical administration for the treatment of glaucoma may led to asthmatic exacerbations. ACE inhibitors are not contraindicated and may be used; very rarely worsen airflow obstruction; produce persistent dry cough and are not first line drug for hypertensive patients with asthma or COPD.

Asthma COPD and Hypertension Diuretics: can be effectively used but there is an increased risk of hypokalemia (inhaled b-2 agonist drive potassium into cell and orally administered corticosteroids mildly increase urinary potassium excretion). Only low dose (12.5-25 mg) of thiaizides to be used. In patients with COPD and chronic hypercapnia, diuretics-induced metabolic alkalosis may suppress the ventilatory drive and exacerbates the hypoxia.

Asthma, COPD and Hypertension Calcium channel blockers (CCB) are preferred for treatment of hypertension in astma & COPD. May be combined with diuretics Short-acting CCB (niphedipine) should not be used because they increase CV risk. Only long-acting CCB or slow-release niphedipine formulation should be used.

Ischemic Heart Disease and Hypertension IHD is the most common form of target-organ damage associated with hypertension. Beta blockers and long acting Ca++ channel blockers are the first choice in HTN patient with stable angina pectoris. HTN patients with unstable angina or MI should be treated with beta blocker or ACE inhibitor. In patients with post-myocardial infarction, ACE inhibitors, beta blockers and aldosterone antagonists; all reduce progression of left ventricular dysfunction and mortality.

Hart Failure and Hypertension ACE inhibitors and beta blockers are recommended for HTN patients with asymptomatic ventricular dysfunction In HTN patients with symptomatic ventricular dysfunction (NYHA III and IV) in addition to ACE inhibitors and beta blockers, treatment with diuretics, Ang II receptor antagonists and aldosterone antagonists. In hypertensive HF patient, if volume depleted, ACE inhibitors may induce hypotension and acute renal failure. Beta blockers may induce initial/transient worsening of HF.

Pharmacotherapy of Hypertension Pregnancy : Methyl Dopa, Hydralazine Gout & Dyslipidemia: Avoid diuretics Benign prostatic hypertrophy: Alfa-1 adrenergic blockers

Pharmacotherapy of Hypertension Alpha Blocker AT1Antagonist  - agonists ACE Inhibitor Ganglionic blockers Dr. Rx Rational Drug of choice Beta Blocker Vasodilators Ca++ Antagonist Diuretic